Respiratory News: Breaking Respiratory News, Comments and Articles. - Page: 2

02:18 EDT 25th October 2014 | BioPortfolio

Respiratory News - Page: 2Twitter RSS

Read the latest Respiratory News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Respiratory.

Search or Follow Our Respiratory - Page: 2 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Respiratory - Page: 2 News.
You can also follow our Respiratory - Page: 2 news stories on Twitter: @Respiratory_Bio

Showing "respiratory airways lungs breath" News Articles 26 to 50 of 3,000+

Thursday 23rd October 2014

Kimberly-Clark Sterilization Wrap Is Now Most Validated On The Market

ROSWELL, Ga., Oct. 23, 2014 /PRNewswire/ -- Kimberly-Clark Health Care, soon to be Halyard Health, announced today that it is the first and only manufacturer to receive 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use of their sterilization wrap portfolio with all standard sterilization modalities. The KIMGUARD ONE-STEP* and QUICK CHECK* family of sterilization wrap is n...

CHEST Foundation Launches Campaign to Encourage People With COPD to Live Well

GLENVIEW, Ill., Oct. 23, 2014 /PRNewswire/ -- Take Control. Live Well. is the message behind a new chronic obstructive pulmonary disease (COPD) campaign launched today by the CHEST Foundation of the American College of Chest Physicians (CHEST). As part of National COPD Awareness Month in November, the campaign aims to encourage people with COPD to live well by adopting healthy lifestyles, wor...

Generex / Antigen Express to Participate in 2014 BIO-Europe® Annual International Partnering Conference

WORCESTER, Mass. and TORONTO, Oct. 23, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that the Company's wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com), will be participating in the 2014 BIO-Europe® Annual International Partnering Conference being held November 3-5 in Frankfurt, Germany. BIO-Europe® is...

MONQ, LLC Announces the Immediate Availability of MONQ Brand Aromavapes, Merging Aromatherapy with the Technology of Vaping

Palm Beach Gardens, FL, October 23, 2014 --(PR.com)-- MONQ aromavapes are available immediately at www.MONQ.com as well as through select retailers. Merging the ancient art of aromatherapy with modern technology of vaping, MONQ aromavapes contain purely organic plant extracts providing the user with an incredibly flavorful and qualitatively different experience from anything you’ve ever inh...

Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis

Secretion of C–C chemokine ligand 2 (CCL2) by mammary tumours recruits CCR2-expressing inflammatory monocytes to primary tumours and metastatic sites, and CCL2 neutralization in mice inhibits metastasis by retaining monocytes in the bone marrow. He...

Breath-based test can rapidly detect hospital-acquired infections

Isomark has designed a new type of breathalyzer that can spot hospital-acquired infections within two hours of onset.  -More- 

Actavis Confirms Appeals Court Upholds Lo Loestrin® Fe Patent

DUBLIN, Oct. 23, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the United States Court of Appeals for the Federal Circuit has upheld a lower court ruling that found United States Patent No. 7,704,984 (the '984 Patent) to be valid and infringed by Lupin Pharmaceuticals, Inc. and Amneal Pharmaceuticals' Abbreviated New Drug Applications (ANDAs) for generic versions of Actavi...

EJGH Honored By March of Dimes and Louisiana Hospital Association For 39-Week Initiative

East Jefferson General Hospital is one of only eighteen Louisiana hospitals to have reduced the number of elective inductions and cesarean deliveries performed before 39 completed weeks of pregnancy to meet March of Dimes criteria for hospital recognition. This will give more babies a healthy start in life, the March of Dimes says. Metairie, LA (PRWEB) October 23, 2014 East Jefferson General Hosp...

Veterinary research on lambs leads to advances in treatments for respiratory disease in human infants

Veterinary research involving lambs at Iowa State University is helping to advance new treatments to a common virus in humans that sometimes poses a serious threat to newborns.

Novel approach may help detect invasive aspergillosis

Many different microbes can cause pneumonia, and treatment may be delayed or off target if doctors cannot tell which bug is the culprit. A novel approach—analyzing a patient's breath for key chemical compounds made by the infecting microbe—may he...

Wednesday 22nd October 2014

Arkansas Heart Hospital Upgrades to Masimo SET(R) Pulse Oximetry, Resulting in Significant Reduction in False Alarms and Improved Patient Care and Satisfaction

LITTLE ROCK, AR and IRVINE, CA -- (Marketwired) -- 10/23/14 -- Masimo (NASDAQ: MASI) today announced that Arkansas Heart Hospital -- a nationally recognized and award-winning hospital dedicated to the prevention, diagnosis and treatment of cardiovascular disease -- has upgraded hospital-wide to Masimo SET® pulse oximetry, leading to a dramatic reduction in false alarms and a significant increase...

Theravance to Report Third Quarter 2014 Financial Results on October 30, 2014

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 10/23/14 -- Theravance, Inc. (NASDAQ: THRX) announced today that it will release financial results for the period ended September 30, 2014 after market close on Thursday, October 30, 2014. An accompanying conference call will be held at 5:00 p.m. Eastern Daylight Time. To participate in the live call by telephone, please dial (877) 837-3908 from the U....

Five Prime Therapeutics Announces Expansion of Respiratory Disease Research Collaboration and License Agreement With GSK

SOUTH SAN FRANCISCO, Calif., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), today announced an expansion of its respiratory disease research collaboration with GSK that was established in 2012 to identify first-in-class agents and new mechanisms for the treatment of refractory asthma and chronic obstructive pulmonary disease (COPD). The scope of the collaboration w...

'Breath test' shows promise for diagnosing fungal pneumonia

(Infectious Diseases Society of America) Many different microbes can cause pneumonia, and treatment may be delayed or off target if doctors cannot tell which bug is the culprit. A novel approach -- analyzing a patient's breath for key chemical compou...

GSK climbs as revitalization plan revealed

GlaxoSmithKline has announced new plans to get itself back on track after disappointing drug sales and a mounting number of corruption accusations across the globe. Cost reduction strategies in response to the ongoing poor performance of its respirat...

Routine ICU Care May Effectively Treat Even Severe Ebola

A patient with severe Ebola virus infection complicated by gram-negative septicemia, respiratory failure, and encephalopathy responded to routine intensive care. Medscape Medical News

ROUNDUP: GSK Profit Falls; Plans Partial IPO Of ViiV Business

LONDON (dpa-AFX) - GlaxoSmithKline plc (GSK, GSK.L) on Wednesday reported a decline in third-quarter profit, hurt by lower demand for pharmaceutical products - mainly respiratory drug Advair, and ...

Louise Restrick: Whittington respiratory service

Video Louise Restrick: Whittington respiratory service

Sorin gets European rights to Respicardia's sleep apnea device, plus option to buy company

Cardiovascular device firm Sorin Group SPA acquired exclusive rights to distribute Respicardia Inc.’s (implantable therapies to improve respiratory and cardiovascular health) remede neurostimulation system for central sleep apnea (CSA) in select Eu...

GSK Plans £1 Bil. In Cuts As Respiratory Strategy Fails To Deliver

Britain’s biggest drug maker said it will cut costs by £1 billion in three years as sales of its blockbuster Advair continued to fall under increasing pricing pressure; the company also unveiled key management changes, including within its top R&a...

GSK Sets Up For £1 Bil. In Cuts As Respiratory Strategy Fails To Deliver

Britain’s biggest drug maker said it will cut costs by £1 billion in three years as sales of its blockbuster Advair continued to fall under increasing pricing pressure; the company also unveiled key management changes, including within its top R&a...

GlaxoSmithKline lifted by plans to hive off HIV treatment business

Troubled pharma giant GlaxoSmithKline (LON:GSK) was a top performer Wednesday afternoon after announcing plans to spin off its HIV treatment business, ViiV Healthcare. ViiV was created five years ago in partnership with Pfizer and Shionogi, and has s...

GlaxoSmithKline working hard on Ebola vaccine

Troubled pharma giant GlaxoSmithKline (LON:GSK) saw sales fall again in its latest quarter due to weak US sales and a sluggish performance in consumer healthcare. The market was cheered, however, by news that the company is “working hard”...

Yukon Supports MVC Private Equity Fund’s Investment in AccuMED Innovative Technologies, Inc.

Yukon Partners ("Yukon"), a provider of mezzanine financing for middle market private equity transactions, is pleased to announce its subordinated debt and equity investment in AccuMED Innovative Technologies, Inc. (“AccuMED” or the “Company”), a manufacturer of textile-based medical products. The specific terms of the transaction were not disclose...

New Memoir Tells Story of Sister’s Fight to Live Despite Cancer

Author Elissa Merkl lovingly shares the two-year journey she took when her sister Marianne experienced Hodgkins Disease and liver cancer a second time in this new book released by Dog Ear Publishing. GILLETTE, N.J. – (PRWEB) October 22, 2014 -- When Marianne Merkl successfully battled Hodgkins Disease, Stage 4, for a year in 1980, friends and family rejoiced. Forward to 2005, when she faced a re...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks